This is the latest in our Big Story series, the home for MIT Technology Review’s most important, ambitious reporting. You can ...
Questions around a compound of Shiite refugees from Syria in Lebanon show lingering post-Assad fears
A compound in Lebanon housing people who fled Syria after Bashar Assad's fall has faced allegations of harboring Assad ...
Great QBs have ruled the NFL for decades, but increasingly, even they are living in a league driven by the active, ...
There’s no one recipe for success,’ says expert outlining options, best practices for HR in supporting employees ...
The Retirement Savings for Americans Act (RSAA) applies Australia’s best retirement lesson—universality—to the U.S. system.
7don MSNOpinion
Trump accounts leave taxpayers paying the price
The Trump administration this week is rolling out “Trump Accounts,” promising $1,000 in taxpayer money for every child born ...
From smoother scrolling to smarter sharing, underrated apps can make your phone feel easier and more thoughtful to use every ...
Central Securities Corporation trades at a 15.65% discount with a 106.2% 5-year return through concentrated blue chips. Check ...
Learn 15 practical ways to improve Google Ads conversion rates, covering bidding, targeting, ad copy, and landing page ...
Muslim women are rising leaders in impact investing, but despite strong education and income, many in North America remain ...
Our International Value Equity strategy delivered a 35.5% return, producing attractive absolute results and outperforming ...
BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results